Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes

PURPOSE: To determine the effect of ranibizumab on visual acuity (VA) following a 3-year treatment period for patients diagnosed with wet age-related macular degeneration. To establish whether baseline VA and injection frequency influence visual outcomes. PATIENTS AND METHODS: Retrospective review o...

Descripción completa

Detalles Bibliográficos
Autores principales: Razi, Faraz, Haq, Adnaan, Tonne, Prabhu, Logendran, Maharatnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762441/
https://www.ncbi.nlm.nih.gov/pubmed/26937168
http://dx.doi.org/10.2147/OPTH.S97775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762441/
https://www.ncbi.nlm.nih.gov/pubmed/26937168
http://dx.doi.org/10.2147/OPTH.S97775

Ejemplares similares